FARADAY PHARMACEUTICALS

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury. It has in-licensed proprietary liquid formulations of reduced nonmetal gaseous elements developed in the lab of Dr. Mark Roth at the Fred Hutchinson Cancer Center. The company was founded in 2014 and is located in Seattle, Washington.

#People #Financial #Website #More

FARADAY PHARMACEUTICALS

Social Links:

Industry:

Biotechnology Pharmaceutical Therapeutics

Founded:

2014-01-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.faradaypharma.com

Total Employee:

Status:

Active

Contact:

206-452-8700

Email Addresses:

[email protected]

Total Funding:

88 M USD

Technology used in webpage:

Viewport Meta SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Office 365 Mail JsDelivr

Current Employees Featured

stephen-a-hill_image

Stephen A. Hill
Stephen A. Hill CEO @ Faraday Pharmaceuticals
CEO
2015-08-01

patrick-c-rock_image

Patrick C. Rock
Patrick C. Rock General Counsel & Corporate Secretary @ Faraday Pharmaceuticals
General Counsel & Corporate Secretary
2019-11-01

tressa-d-randall_image

Tressa D. Randall
Tressa D. Randall Vice President Regulatory Affairs and Quality @ Faraday Pharmaceuticals
Vice President Regulatory Affairs and Quality
2019-09-01

Founder

christopher-toombs_image

Christopher Toombs

Investors List

arch-venture-partners_image

Official Site Inspections

http://www.faradaypharma.com Semrush global rank: 5.11 M Semrush visits lastest month: 1.6 K

Host Informations
Whois Informations

Loading ...